Anti-Apolipoprotein A II/ApoA-II antibody [EPR2913]
- RabMAb
- Recombinant
- What is this?
5
(1 Review)
|
(11 Publications)
Rabbit Recombinant Monoclonal Apolipoprotein A II/ApoA-II antibody. Suitable for WB, ICC/IF and reacts with Human samples. Cited in 11 publications.
View Alternative Names
Apolipoprotein A-II, Apo-AII, ApoA-II, Apolipoprotein A2, APOA2
- ICC/IF
AbReview56149****
Immunocytochemistry/ Immunofluorescence - Anti-Apolipoprotein A II/ApoA-II antibody [EPR2913] (AB92478)
Immunocytochemistry/Immunofluorescence analysis rat primary astrocyte culture labelling Apolipoprotein A II/ApoA-II with ab92478 at 1/500. Cells were fixed with methanol and permeabilised using 0.1M PBS with 1% Triton X. An Alexa Fluor® 488-conjugated monoclonal donkey antibody at 1/3000 dilution was used as the secondary antibody.
This image is courtesy of an abreview submitted by Ruma Raha-Chowdhury
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Apolipoprotein A II/ApoA-II antibody [EPR2913] (AB92478)
ab92478 at 1/100 dilution staining Apolipoprotein A II/ApoA-II in HepG2 cells by immunofluorescence.
- WB
Unknown
Western blot - Anti-Apolipoprotein A II/ApoA-II antibody [EPR2913] (AB92478)
All lanes:
Western blot - Anti-Apolipoprotein A II/ApoA-II antibody [EPR2913] (ab92478) at 1/1000 dilution
All lanes:
Human plasma lysate at 10 µg
Secondary
All lanes:
HRP labelled goat anti-rabbit antibody at 1/2000 dilution
Predicted band size: 11 kDa
Observed band size: 11 kDa
false
Related conjugates and formulations (1)
-
Anti-Apolipoprotein A II/ApoA-II antibody [EPR2913] - BSA and Azide free
Reactivity data
Product details
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Apolipoprotein A-II serves as a significant regulator of HDL metabolism and lipid transport. It is an integral part of HDL particles contributing to their stability and function. Apolipoprotein A-II influences lecithin-cholesterol acyltransferase (LCAT) activity which affects cholesterol esterification. Although less studied than its counterpart Apolipoprotein A-I ApoA-II's interaction with lipids and proteins such as CETP (cholesteryl ester transfer protein) suggests its involvement in lipid exchange and reverse cholesterol transport processes.
Pathways
Apolipoprotein A-II impacts the reverse cholesterol transport pathway and lipid metabolic processes. ApoA-II works closely with its relative Apolipoprotein A-I both part of the same HDL complex. Together they play essential roles in maintaining cholesterol homeostasis and promoting cholesterol efflux from cells back to the liver. The mechanism by which it modulates the function of lipoprotein lipase and hepatic lipase further implicates its role in lipid metabolism and energy balance processes.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (11)
Recent publications for all applications. Explore the full list and refine your search
Biology 14: PubMed40136514
2025
Applications
Unspecified application
Species
Unspecified reactive species
BMC pregnancy and childbirth 25:21 PubMed39789492
2025
Applications
Unspecified application
Species
Unspecified reactive species
Reproductive sciences (Thousand Oaks, Calif.) 31:1573-1585 PubMed38177949
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 14:4007 PubMed37414857
2023
Applications
Unspecified application
Species
Unspecified reactive species
Science advances 9:eade0293 PubMed37235655
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 22: PubMed34360674
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of atherosclerosis and thrombosis 28:730-741 PubMed32999208
2021
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 294:19022-19033 PubMed31666337
2019
Applications
Unspecified application
Species
Unspecified reactive species
Biomedicine & pharmacotherapy = Biomedecine & phar 118:109251 PubMed31351426
2019
Applications
Unspecified application
Species
Unspecified reactive species
Journal of lipid research 58:2220-2228 PubMed28893842
2017
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com